AKBA earnings: a positive outcome, +7.3%

On November 3, 2022, Akebia Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +7.3% in the window around the event. It had already run -21.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.